Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.2 USD | -0.62% | -5.86% | -13.16% |
10/05 | Wedbush Trims Xenon Pharmaceuticals' Price Target to $50 From $51, Maintains Outperform Rating | MT |
09/05 | Xenon Pharmaceuticals Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.16% | 305.25Cr | |
+6.68% | 11TCr | |
+10.97% | 11TCr | |
+0.84% | 2.23TCr | |
-12.58% | 2.22TCr | |
-5.57% | 1.94TCr | |
-37.85% | 1.79TCr | |
-6.41% | 1.72TCr | |
+7.57% | 1.43TCr | |
+34.56% | 1.25TCr |
- Stock Market
- Equities
- XENE Stock
- News Xenon Pharmaceuticals Inc.
- Needham Adjusts Xenon Pharmaceuticals' Price Target to $50 From $48, Maintains Buy Rating